Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Helicobacter biology--discovery

M J Buckley1, C A O'Morain

  • 1Service de Hepato-Gastroenterologie, Hôpital de l'Archet II, CHU, Nice, France.

British Medical Bulletin
|May 30, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.

Gut·2016
Same author

An open-label, phase 2, single centre, randomized, crossover design bioequivalence study of AndroForte 5 testosterone cream and Testogel 1% testosterone gel in hypogonadal men: study LP101.

Andrology·2016
Same author

Nitrous oxide does not depress left ventricular contractility in ischemic rat heart.

Journal of anesthesia·2013
Same author

Letter: the ethics of using inferior regimens in H. pylori randomised trials - invited comment.

Alimentary pharmacology & therapeutics·2012
Same author

Review article: the effects of antitumour necrosis factor-α on bone metabolism in inflammatory bowel disease.

Alimentary pharmacology & therapeutics·2011
Same author

Use of Infliximab as rescue therapy in acute severe Ulcerative Colitis with recent norovirus infection.

Journal of Crohn's & colitis·2010

Gastric spirochaetal organisms, initially dismissed as contaminants, were successfully cultured in 1982. Their link to gastritis and peptic ulcers, later identified as Helicobacter pylori, revolutionized gastroduodenal disease management.

Area of Science:

  • Gastroenterology
  • Microbiology

Background:

  • Gastric spirochaetal organisms were documented over a century ago but largely ignored by the medical community.
  • Previous reports of spiral bacteria in the stomach were considered contaminants.

Observation:

  • In 1982, researchers successfully cultured 'Campylobacter-like organisms' from gastric biopsy specimens.
  • The presence of these organisms was associated with gastritis and potentially peptic ulceration.

Findings:

  • The discovery of Helicobacter pylori's role in gastroduodenal diseases has been pivotal.
  • This organism is now recognized as a key factor in various gastrointestinal conditions.

Implications:

  • Understanding Helicobacter pylori has revolutionized the diagnosis and treatment of gastroduodenal diseases.

Related Experiment Videos

  • Management of peptic ulcer disease has significantly improved due to the acceptance of an infectious etiology.